124 related articles for article (PubMed ID: 34364721)
1. Less extensive surgery for low-risk papillary thyroid cancers post 2015 American Thyroid Association guidelines in an Australian tertiary centre.
Adhami M; Bhatt CR; Grodski S; Serpell J; Lee JC
Eur J Surg Oncol; 2021 Nov; 47(11):2781-2787. PubMed ID: 34364721
[TBL] [Abstract][Full Text] [Related]
2. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
3. Risk of needing completion thyroidectomy for low-risk papillary thyroid cancers treated by lobectomy.
DiMarco AN; Wong MS; Jayasekara J; Cole-Clark D; Aniss A; Glover AR; Delbridge LW; Sywak MS; Sidhu SB
BJS Open; 2019 Jun; 3(3):299-304. PubMed ID: 31183445
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of hemithyroidectomy in papillary thyroid carcinoma with minimal extrathyroidal extension.
Ji YB; Song CM; Kim D; Sung ES; Lee DW; Chung MS; Tae K
Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3435-3442. PubMed ID: 31414221
[TBL] [Abstract][Full Text] [Related]
5. Trends in the Management of Localized Papillary Thyroid Carcinoma in the United States (2000-2018).
Pasqual E; Sosa JA; Chen Y; Schonfeld SJ; Berrington de González A; Kitahara CM
Thyroid; 2022 Apr; 32(4):397-410. PubMed ID: 35078347
[No Abstract] [Full Text] [Related]
6. Temporal analysis of thyroid cancer management in a Melbourne tertiary centre.
Lee JC; Chang P; Grodski S; Yeung M; Johnson W; Serpell J
ANZ J Surg; 2019 Jan; 89(1-2):38-42. PubMed ID: 27758032
[TBL] [Abstract][Full Text] [Related]
7. Lobectomy and completion thyroidectomy rates increase after the 2015 American Thyroid Association Differentiated Thyroid Cancer Guidelines update.
Worrall BJ; Papachristos A; Aniss A; Glover A; Sidhu SB; Clifton-Bligh RJ; Learoyd D; Tsang VHM; Gild M; Robinson BG; Sywak MS
Endocr Oncol; 2023 Jan; 3(1):e220095. PubMed ID: 37434647
[TBL] [Abstract][Full Text] [Related]
8. Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center.
Dobrinja C; Troian M; Cipolat Mis T; Rebez G; Bernardi S; Fabris B; Piscopello L; Makovac P; Di Gregorio F; de Manzini N
Int J Surg; 2017 May; 41 Suppl 1():S40-S47. PubMed ID: 28506412
[TBL] [Abstract][Full Text] [Related]
9. Postoperative Surveillance in Older Adults With T1N0M0 Low-risk Papillary Thyroid Cancer.
Pradhan MC; Kazaure HS; Wang F; Zambeli-Ljepovic A; Perkins JM; Stang MT; Scheri RP
J Surg Res; 2021 Aug; 264():37-44. PubMed ID: 33765509
[TBL] [Abstract][Full Text] [Related]
10. Favorable Early Outcomes With Thyroid Lobectomy for Low-Risk Papillary Thyroid Cancer: The Mayo Clinic Experience.
Merten MM; Foster T; Lyden M; Henry M; Regina Castro M
Am Surg; 2021 Sep; 87(9):1374-1378. PubMed ID: 34468234
[TBL] [Abstract][Full Text] [Related]
11. Total vs hemithyroidectomy for intermediate risk papillary thyroid cancer: A 23 year retrospective study in a tertiary center.
Tsui KP; Kwan WY; Chow TL
Am J Otolaryngol; 2019; 40(3):431-434. PubMed ID: 30956005
[TBL] [Abstract][Full Text] [Related]
12. Cervical Lymph Node Dissection for Papillary Thyroid Cancers: A Decade Experience of a Single Surgical Team.
Simescu R; Constantinescu D; Sălceriu D; Muntean V
Chirurgia (Bucur); 2019; 114(5):586-593. PubMed ID: 31670634
[No Abstract] [Full Text] [Related]
13. Efficacy of prophylactic central neck dissection in hemithyroidectomy for papillary thyroid carcinoma.
Jin SH; Kim IS; Ji YB; Song CM; Chung MS; Tae K
Eur Arch Otorhinolaryngol; 2020 Mar; 277(3):873-879. PubMed ID: 31792652
[TBL] [Abstract][Full Text] [Related]
14. Preoperative ultrasound characteristics in determining the likelihood of requiring completion thyroidectomy for cytologically confirmed (Bethesda VI) papillary thyroid tumors with 1 - 4 cm in diameter.
Leong D; Ng K; Nguyen H; Ryan S
Asian J Surg; 2022 Jan; 45(1):197-201. PubMed ID: 34052082
[TBL] [Abstract][Full Text] [Related]
15. Revisiting the guidelines issued by the Japanese Society of Thyroid Surgeons and Japan Association of Endocrine Surgeons: a gradual move towards consensus between Japanese and western practice in the management of thyroid carcinoma.
Takami H; Ito Y; Okamoto T; Onoda N; Noguchi H; Yoshida A
World J Surg; 2014 Aug; 38(8):2002-10. PubMed ID: 24671301
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
Zhao H; Huang T; Li H
Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667
[TBL] [Abstract][Full Text] [Related]
17. Total thyroidectomy with therapeutic level II-IV neck dissection for papillary thyroid carcinoma: level VI recurrence patterns.
Carmel-Neiderman NN; Duek I; Amsterdam D; Wengier A; Kuzmenko B; Ringel B; Warshavsky A; Shapira U; Horowitz G; Izkhakov E; Fliss DM
Eur Arch Otorhinolaryngol; 2020 Dec; 277(12):3449-3455. PubMed ID: 32488373
[TBL] [Abstract][Full Text] [Related]
18. Lobectomy Compared to Total Thyroidectomy for Low-Risk Papillary Thyroid Cancer: A Systematic Review.
Vargas-Pinto S; Romero Arenas MA
J Surg Res; 2019 Oct; 242():244-251. PubMed ID: 31103828
[TBL] [Abstract][Full Text] [Related]
19. The Identification of Intraoperative Risk Factors Can Reduce, but Not Exclude, the Need for Completion Thyroidectomy in Low-Risk Papillary Thyroid Cancer Patients.
Craig SJ; Bysice AM; Nakoneshny SC; Pasieka JL; Chandarana SP
Thyroid; 2020 Feb; 30(2):222-228. PubMed ID: 31813323
[No Abstract] [Full Text] [Related]
20. Predictors of recurrence after total thyroidectomy plus neck dissection and radioactive iodine ablation for high-risk papillary thyroid carcinoma.
Kim Y; Roh JL; Song D; Cho KJ; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2020 Oct; 122(5):906-913. PubMed ID: 32588461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
